A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/12 (2006.01) A61K 31/122 (2006.01) C07C 403/24 (2006.01)
Patent
CA 2405479
A method of inhibiting the expression of inflammatory cytokines and chemokines in an animal or man, is disclosed. The method comprises administration to said animal or man of at least one type of xanthophyll, e.g. astaxanthin, in an amount inhibiting the expression of inflammatory cytokines and chemokines in said animal or man. Use of at least one type of xanthophyll, such as astaxanthin, for the preparation of a medicament for the prophylactic and/or therapeutic inhibition of the expression of inflammatory cytokines and chemokines in an animal or man, is described. Further, a commercial package containing a medicament comprising at least one type of xanthophyll, e.g. astaxanthin, and written and/or data carrier instructions for administation to an animal or man of the medicament for the prophylactic and/or therapeutic inhibition of the expression of inflammatory cytokines and chemokines, is disclosed.
L'invention concerne un procédé d'inhibition de l'expression de cytokines et de chimiokines inflammatoires d'un homme ou d'un animal. Ce procédé consiste à administrer à cet homme ou animal au moins un type de xanthophylle, par exemple, de l'astaxanthine, dans une quantité inhibant l'expression de cytokines ou chimiokines inflammatoires chez cet homme ou animal. L'invention concerne également l'utilisation d'au moins un type de xanthophylle, telle que l'astaxanthine, pour la préparation d'un médicament destiné à l'inhibition préventive et/ou thérapeutique de l'expression de cytokines et de chimiokines inflammatoires chez un homme ou un animal. L'invention concerne enfin un emballage commercial contenant un médicament comprenant au moins un type de xanthophylle, par exemple, de l'astaxanthine, et des instructions écrites et/ou support de données destinées à l'administration à un homme ou un animal du médicament d'inhibition préventive et/ou thérapeutique de l'expression de cytokines et de chimiokines inflammatoires.
Andersson Tove
Pettersson Sven
Astacarotene Ab
Fetherstonhaugh & Co.
LandOfFree
Method of inhibiting the expression of inflammatory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting the expression of inflammatory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting the expression of inflammatory... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1530867